摘要
目的:观察MEF2D在鼻咽癌组织中的表达,结合鼻咽癌患者的1~7年的随访资料,探讨MEF2D在鼻咽癌早期转移、预后方面的作用。方法:选取鼻咽癌患者的鼻咽部标本101例,免疫组织化学检测MEF2D在组织中的蛋白表达,并进行差异性分析、生存分析。结果:①在鼻咽癌的4个临床分期中,MEF2D的表达具有统计学差异:临床分期越高,MEF2D表达阳性水平也升高;②MEF2D的单位吸光度值与灰度呈直线负相关关系(︱r︱=0.865,P<0.01),免疫组织化学分级与灰度值呈直线负相关关系(︱r︱=0.959,P<0.01);③放化疗后的鼻咽癌患者5年生存率为52.5%,在4个临床分期中,1期的生存曲线较4期生存曲线高,有统计学意义(P<0.05);④鼻咽癌标本的MEF2D4个分级中,生存曲线无统计学意义(P>0.05)。结论:MEF2D的表达差异在鼻咽癌患者的临床分期中具有统计学意义,但在其生存曲线分析中无统计学意义,提示MEF2D与鼻咽癌的侵袭、转移性有关,与鼻咽癌患者的预后无明显关联。
Objective: To explore the expression of MEF2D in NPC tissures,study the relationship between the expression and prognostic. Method: Specimens from 101 NPC patients who were follow-up visited 1 to 7 years were analyzed for MEF2D by using immunohistochemistry. Result: ①The expression of MEF2D was higher in the higher clinical stage.②Density and Grey of MEF2D was negative correlated(︱r︱=0.865,P0.01).③NPC patients'suvival rate after therapies was 52.5%,the survival curve of 1th clinical stage was higer than 4th.④The survival curves of MEF2D stages were no statistical significance. Conclusion: There's statistical significance of the MEF2D expression in clinical stages,but not in survival curve,which indicated that MEF2D concerned with invasion and metastatic of NPC.
出处
《临床耳鼻咽喉头颈外科杂志》
CAS
CSCD
北大核心
2011年第18期840-842,847,共4页
Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词
鼻咽肿瘤
早期转移
预后
MEF2D
nasopharyngeal neoplasms
inchoate metastasis
prognosis
MEF2D